HFA Premium Access

Cardio-renal-metabolic overlap, outcomes, and treatment with dapagliflozin in heart failure with mildly reduced or preserved ejection fraction

Congress Presentation

About the speaker

Doctor John Ostrominski

Brigham and Women's Hospital, Harvard Medical School, Boston (United States of America)
0 follower

7 more presentations in this session

Impact of anemia on long-term clinical outcome in patients with mildly reduced left ventricular systolic function after acute myocardial infarction

Speaker: Doctor J. Seung (Seoul, KR)

Thumbnail

Cardio-renal-metabolic syndrome in a cohort of patients with chronic heart failure: prevalence and prognosis. An analysis of OFFICE IC AR Registry

Speaker: Doctor J. Thierer (Buenos Aires, AR)

Thumbnail

The patter of muscle mass wasting in elder patients with heart failure is associated with mortality: a post-hoc analysis of the FRAGILE-HF

Speaker: Mr T. Sunayama (Tokyo, JP)

Thumbnail

Soluble transferrin receptor as a marker of tissue iron deficiency: impact on cardiac, systemic, hematinic and neurohormonal biomarkers in patients with heart failure without systemic iron deficiency

Speaker: Doctor R. Ramos Polo (Hospitalet De Llobregat, ES)

Thumbnail

REVEAL-CKD: Prevalence of undiagnosed stage 3 chronic kidney disease in patients with heart failure in Canada

Speaker: Doctor K. Jarbrink (Gothenburg, SE)

Thumbnail

Access the full session

Chronic heart failure - comorbidities

Speakers: Doctor J. Ostrominski, Doctor J. Seung, Doctor J. Thierer, Mr T. Sunayama, Doctor R. Ramos Polo...
Thumbnail

About the event

Image

Heart Failure 2023

20 May - 23 May 2023

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb